Sexual health as a survivorship issue for female cancer survivors

Oncologist

Volumn 19, Issue 2, 2014, Pages 202-210

  Dizon, Don S ^a,b   Suzin, Daphne ^a   Mcilvenna, Susanne ^a  

^a Gillette Center for Gynecologic Oncology   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Cancer survivor; Gynecologic cancer; Quality of life; Sexual health

Indexed keywords

FEMALE; HUMAN; NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SEXUAL BEHAVIOR; SURVIVOR;

FEMALE; HUMANS; NEOPLASMS; SEXUAL BEHAVIOR; SURVIVORS;

EID: 84894031843     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0302     Document Type: Article

References (80)

1. National Coalition for Cancer Survivorship Mission: While we hope for the cure, we must focus on the care. Available at: http://www.canceradvocacy. org/about-us/our-mission/. Accessed 10/13/2013.
2. American Cancer Society. Cancer facts&figures 2013. Available at http://www.cancer.org/research/ cancerfactsfigures/cancerfactsfigures/cancer-factsfigures-2013. Accessed 10/23/13.
3. de Moor JS, Mariotto AB, Parry C et al. Cancer survivors in the United States: Prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev 2013;22: 561-570.
4. GLOBOCAN 2008 Update: Cancer prevalence estimates are now available. Available at: http:// www.iarc.fr/en/media-centre/iarcnews/2011/ globocan2008-prev.php. Accessed 10/23/13.
5. Desimone M, Spriggs E, Gass JS et al. Sexual dysfunction in female cancer survivors. Am J Clin Oncol 2012 [Epub ahead of print].
6. MastersW, Johnson V. Human Sexual Response. New York, NY: Little Brown & Co., 1966.
7. Kaplan HS, Horwith M. The Evaluation of Sexual Disorders: Psychological and Medical Aspects. Abingdon, U.K.: Brunner/Mazel, 1983.
8. Basson R. Female sexual response: The role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001;98:350-353.
9. Sand M, Fisher WA. Women's endorsement of models of female sexual response: The nurses' sexuality study. J Sex Med 2007;4:708-719.
10. Kornblith AB, Herndon JE II, Zuckerman E et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 2001;91:443-454.
11. Brotto LA, Yule M, Breckon E. Psychological interventions for the sexual sequelae of cancer: A review of the literature. J Cancer Surviv 2010;4: 346-360.
12. LiQ, Loke AY. A literature review on the mutual impact of the spousal caregiver-cancer patients dyads: 'Communication', 'reciprocal influence', and 'caregiver-patient congruence.' Eur J Oncol Nurs 2013 [Epub ahead of print].
13. Manne S, Badr H. Intimacy and relationship processes in couples' psychosocial adaptation to cancer. Cancer 2008;112(suppl):2541-2555.
14. Perelman MA. The sexual tipping point: A mind/body model for sexual medicine. J Sex Med 2009;6:629-632.
15. Andersen BL. Sexual functioning morbidity among cancer survivors. Current status and future research directions. Cancer 1985;55:1835-1842.
16. Hsu T, Ennis M, Hood N et al. Quality of life in long-term breast cancer survivors. J Clin Oncol 2013; 31:3540-3548.
17. Le Borgne G, Mercier M, Woronoff AS et al. Quality of life in long-term cervical cancer survivors: Apopulation-based study. Gynecol Oncol 2013;129: 222-228.
18. Ganz PA, Desmond KA, Leedham B et al. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 2002;94:39-49.
19. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 2003;30:799-813.
20. Ganz PA. Sexual functioning after breast cancer: A conceptual framework for future studies. Ann Oncol 1997;8:105-107.
21. Beckjord E, Campas BE. Sexual quality of life in women with newly diagnosed breast cancer. J Psychosoc Oncol 2007;25:19-36.
22. Burwell SR, Case LD, Kaelin C et al. Sexual problems in younger women after breast cancer surgery. J Clin Oncol 2006;24:2815-2821.
23. Wilmoth MC. The aftermath of breast cancer: An altered sexual self. Cancer Nurs 2001;24: 278-286.
24. Bergmark K, Avall-Lundqvist E, Dickman PW et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340: 1383-1389.
25. Becker M, Malafy T, BossartMet al. Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol 2011;121:169-173.
26. Wilmoth MC, Hatmaker-Flanigan E, LaLoggia V et al. Ovarian cancer survivors: Qualitative analysis of the symptom of sexuality. Oncol Nurs Forum 2011;38:699-708.
27. Reese JB et al. Gastrointestinal ostomies and sexual outcomes: A comparison of colorectal cancer patients by ostomy status. Support Care Cancer 2013 [Epub ahead of print].
28. Panjari M, Bell RJ, Burney S et al. Sexual function, incontinence, and wellbeing in women after rectal cancer-a review of the evidence. J Sex Med 2012;9:2749-2758.
29. Böhm G, Kirschner-Hermanns R, Decius A et al. Anorectal, bladder, and sexual function in females following colorectal surgery for carcinoma. Int J Colorectal Dis 2008;23:893-900.
30. Hendren SK, O'Connor BI, Liu M et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005; 242:212-223.
31. Boehmer U, Glickman M, Winter M, Clark MA. Lesbian and bisexual women's adjustment after a breast cancer diagnosis. J Am Psychiatr Nurses Assoc 2013;19:280-92.
32. Jensen PT, Groenvold M, Klee MC et al. Earlystage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004; 100:97-106.
33. Figueiredo MI, Cullen J, Hwang Y-T et al. Breast cancer treatment in older women: Does getting what you want improve your long-term body image and mental health? J Clin Oncol 2004;22:4002-4009.
34. Fobair P, Stewart SL, Chang S et al. Body image and sexual problems in young women with breast cancer. Psychooncology 2006;15:579-594.
35. Roe H. Chemotherapy-induced alopecia: Advice and support for hair loss. Br J Nurs 2011;20: S4-S11.
36. Krychman ML, Carter J, Aghajanian CA et al. Chemotherapy-induced dyspareunia: A case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma. Gynecol Oncol 2004;93:561-563.
37. Baumgart J, Nilsson K, Evers AS et al. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 2013;20: 162-168.
38. Pieterse QD, Maas CP, ter Kuile MM et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer 2006;16:1119-1129.
39. Kelemen G, Varga Z, Lázár G et al. Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy. Pathol Oncol Res 2012;18:421-427.
40. Marwick C. Survey says patients expect little physician help on sex. JAMA 1999;281:2173-2174.
41. The Pfizer Global Study of Sexual Attitudes and Behaviors. Available at http://www.pfizerglobalstudy. com/study/study-results.asp. Accessed 5/7/2011.
42. Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425-427.
43. Ussher JM, Perz J, Gilbert E et al. Talking about sex after cancer: A discourse analytic study of health care professional accounts of sexualcommunication with patients. Psychol Health 2013;28:1370-1390.
44. Wiggins DL, Wood R, Granai CO et al. Sex, intimacy, and the gynecologic oncologists: Survey results of the New England Association of Gynecologic Oncologists (NEAGO). J Psychosoc Oncol 2007; 25:61-70.
45. Hordern A. Intimacy and sexuality for the woman with breast cancer. Cancer Nurs 2000;23: 230-236.
46. Hordern AJ, Street AF. Let's talk about sex: Risky business for cancer and palliative care clinicians. Contemp Nurse 2007;27:49-60.
47. Parish SJ, Rubio-Aurioles E. Education in sexual medicine: Proceedings from the International Consultation in Sexual Medicine, 2009. J Sex Med 2010;7:3305-3314.
48. Hill EK et al. Aprospective evaluation of quality of life, sexual function, and depression in women referred to a sexuality clinic for female cancer survivors. Gynecol Oncol 2013;125:278a.
49. Annon JS. Behavioral Treatment of Sexual Problems: Brief Therapy. New York, NY: Harper & Row, 1976;45.
50. Park ER, Norris RL, Bober SL. Sexual health communication during cancer care: Barriers and recommendations. Cancer J 2009;15:74-77.
51. Lindau ST, Schumm LP, Laumann EO et al. A study of sexuality and health among older adults in the United States. N Engl JMed 2007;357:762-774.
52. Perz J, Ussher JM, Gilbert E. Constructions of sex and intimacy after cancer: Qmethodology study of people with cancer, their partners, and health professionals. BMC Cancer 2013;13:270.
53. Althof SE, Parish SJ. Clinical interviewing techniques and sexuality questionnaires for male and female cancer patients. J Sex Med 2013;10 (Suppl 1):35-42.
54. Frechette D, Paquet L, VermaSet al. Theimpact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: Encouraging results from a prospective study. Breast Cancer Res Treat 2013;141:111-117.
55. Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 2012;118:4606-4618.
56. Tracy JK, Junginger J. Correlates of lesbian sexual functioning. J Womens Health (Larchmt) 2007;16:499-509.
57. Meyer-Bahlburg HFL, Dolezal C. The Female Sexual Function Index: A methodological critique andsuggestions for improvement. J Sex Marital Ther 2007;33:217-224.
58. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association, 2013.
59. Krychman ML, Katz A. Breast cancer and sexuality: Multi-modal treatment options. J Sex Med 2012;9:5-13; quiz 14-15.
60. Krychman ML. Sexual rehabilitation medicine in a female oncology setting. Gynecol Oncol 2006; 101:380-384.
61. Simunić V, Banović I, Ciglar S et al. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003;82:187-197.
62. Kendall A, Dowsett M, Folkerd E et al. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-587.
63. Le Ray I, Dell'Aniello S, Bonnetain F et al. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: A nested case-control study. Breast Cancer Res Treat 2012;135:603-609.
64. Portman DJ, Bachmann GA, Simon JA; Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 2013;20:623-630.
65. Davis SR, Moreau M, Kroll R et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005-2017.
66. Nathorst-Böös J, Flöter A, Jarkander-Rolff M et al. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido-effectsonsexuality and psychological general well-being. Maturitas 2006;53:11-18.
67. Kingsberg S, Shifren J, Wekselman K et al. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007;4: 1001-1008.
68. Shifren JL, Braunstein GD, Simon JA et al. Transdermal testosterone treatment inwomenwith impaired sexual function after oophorectomy. N Engl JMed 2000;343:682-688.
69. Barton DL, Wender DB, Sloan JA et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 2007;99: 672-679.
70. Labrie F, Martel C, Bérubé R et al. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. J Steroid Biochem Mol Biol 2013;138:359-367.
71. Katz M, DeRogatis LR, Ackerman R et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trial. J Sex Med 2013;10:1807-1815.
72. Loprinzi CL, Abu-Ghazaleh S, Sloan JA et al. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 1997;15:969-973.
73. Lee Y-K, Chung HH, Kim JW et al. Vaginal pHbalanced gel for the control of atrophic vaginitis among breast cancer survivors: A randomized controlled trial. Obstet Gynecol 2011;117:922-927.
74. Costantino D, Guaraldi C. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: An open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci 2008;12:411-416.
75. Herbenick D, Reece M, Hensel D et al. Association of lubricant use with women's sexual pleasure, sexual satisfaction, and genital symptoms: A prospective daily diary study. J Sex Med 2011;8: 202-212.
76. Kurowecki D, Fergus KD. Wearing my heart on my chest: Dating, new relationships, and the reconfiguration of self-esteem after breast cancer. Psychooncology 2013 [Epub ahead of print].
77. Derogatis L, Clayton A, Lewis-D'Agostino D et al. Validation of the female sexual distress scalerevised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008; 5:357-364.
78. HopwoodP, Fletcher I, LeeAet al. Abodyimage scale for use with cancer patients. Eur J Cancer 2001; 37:189-197.
79. Spanier GB. The measurement of marital quality. J Sex Marital Ther 1979;5:288-300.
80. Schaefer MT, Olson DH. Assessing intimacy: The Pair Inventory. J Marital Fam Ther 1981;7: 47-60.